Eye drop platform for delivering active ingredients to anterior chamber tissue and / or posterior chamber tissue of eye, uses of delivery composition, complex formulation containing the delivery composition, and use of complex formulation

TW202639117APending Publication Date: 2026-10-01IND TECH RES INST
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114151426
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-30
Filing Date
2025-12-26
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078900_001
    Figure TWG2TA001078900_001
  • Figure TWG2TA001078900_002
    Figure TWG2TA001078900_002
  • Figure TWG2TA001078900_003
    Figure TWG2TA001078900_003
Patent Text Reader

Abstract

An eye drop platform for delivering active ingredients to anterior chamber tissue and / or posterior chamber tissue of eye is provided. The eye drop platform for delivering active ingredients to anterior chamber tissue and / or posterior chamber tissue of eye includes a delivery composition and a pharmaceutically acceptable solvent for dissolving the delivery composition to form a solution as the eye drop platform for delivering active ingredients to anterior chamber tissue and / or posterior chamber tissue of eye. The delivery composition includes cyclodextrin and / or a derivative thereof, and caffeine. The concentration of the cyclodextrin and / or the derivative thereof in the solution is
Need to check novelty before this filing date? Find Prior Art